RAVYN BARR: Open Payments
NPI 1225510647 · LUBBOCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$697 in 50 payments from 9 companies in 2025. Trend: 2023 $1,309 · 2024 $971 · 2025 $697
Food & beverage: $697
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 26 | $290 |
| UCB, Inc. | 13 | $205 |
| Radius Health, Inc. | 3 | $65 |
| ABBVIE INC. | 2 | $34 |
| GlaxoSmithKline, LLC. | 2 | $28 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $25 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
| Actelion Pharmaceuticals US, Inc. | 1 | $14 |
| Organon LLC | 1 | $12 |
Products named: Bimzelx, TAVNEOS, KRYSTEXXA, Tymlos, OTEZLA, EVENITY, BENLYSTA, SPEVIGO.
Industry payments across TX — which companies pay providers there.
